Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of HSK3486 in Healthy Subjects
NCT04033939Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Apr 2014
- Primary completion
- Nov 2014
- Modality
- Allosteric Modulators
01
Overview
Phase 1, randomised, double-blind trial of ciprofol in Anesthesia and sedation (4 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoint: Safety by measurement of Adverse Events at Day 1. Started Apr 2014; status: completed.
02
Drugs
ciprofol
03
Conditions
Anesthesiasedation
Beyond the preview
Go deeper on NCT04033939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04033939.